Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Scientific Reports
|
April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Scientific Reports
|
June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
Jaspreet Toor, Emily R Adams, Maryam Aliee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
Andreia Vasconcelos, Jonathan D King, Cláudio Nunes-Alves, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Scientific Reports
|
April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.
Scientific Reports
|
June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2020
Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
Jaspreet Toor, Emily R Adams, Maryam Aliee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
Andreia Vasconcelos, Jonathan D King, Cláudio Nunes-Alves, et al.
Page
of 16